Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
2022 · Nature Communications · 231 citations
https://doi.org/10.1038/s41467-022-30895-3
H
Houssein H. Ayoub
Qatar University(QA)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
171
Papers
6.5K
Citations
41
h-index
91
i10-index
Houssein H. Ayoub is an academic researcher from Qatar University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & COVID-19 epidemiological studies. The author has an h-index of 41, co-authored 146 publications.
ORCID: 0000-0003-2512-6657Papers by this author
worksCharacterizing the Qatar advanced-phase SARS-CoV-2 epidemic
2021 · Scientific Reports · 165 citations
https://doi.org/10.1038/s41598-021-85428-7
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
2022 · Nature Communications · 81 citations
https://doi.org/10.1038/s41467-022-32363-4
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
2022 · New England Journal of Medicine · 81 citations
https://doi.org/10.1056/nejmc2211055
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
2022 · The Lancet Microbe · 74 citations
https://doi.org/10.1016/s2666-5247(22)00287-7
Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
2021 · Global Epidemiology · 54 citations
https://doi.org/10.1016/j.gloepi.2021.100068
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat